PRIMARY STUDY
Cannabis sativa as a Treatment for Obesity: From Anti-Inflammatory Indirect Support to a Promising Metabolic Re-Establishment Target
Key Findings: Phytocannabinoids from Cannabis sativa may be a useful option to reduce and reverse inflammation and comorbidities associated with obesity due to its anti-inflammatory, antioxidant, and neuroprotective properties.
Type of Study: Meta-analysis
Study Result: Positive
Research Location(s): Brazil
Year of Pub: 2021
Cannabinoids Studied: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Tetrahydrocannabivarin (THCV)
Phytocannabinoid Source: Unspecified
Citation: Cavalheiro EKFF, et al. Cannabis sativa as a Treatment for Obesity: From Anti-Inflammatory Indirect Support to a Promising Metabolic Re-Establishment Target. Cannabis Cannabinoid Res. 2022; 7:135-151. doi: 10.1089/can.2021.0016
Authors: Cavalheiro EKFF, Costa AB, Salla DH, Silva MRD, Mendes TF, Silva LED, Turatti CDR, Bitencourt RM, Rezin GT
